MX2008000070A - Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona. - Google Patents

Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona.

Info

Publication number
MX2008000070A
MX2008000070A MX2008000070A MX2008000070A MX2008000070A MX 2008000070 A MX2008000070 A MX 2008000070A MX 2008000070 A MX2008000070 A MX 2008000070A MX 2008000070 A MX2008000070 A MX 2008000070A MX 2008000070 A MX2008000070 A MX 2008000070A
Authority
MX
Mexico
Prior art keywords
receptor modulators
progesterone receptor
well
therapy
benzofuranone derivatives
Prior art date
Application number
MX2008000070A
Other languages
English (en)
Spanish (es)
Inventor
Norbert Schmees
Wolfgang Schwede
Ulrike Fuhrmann
Carsten Moeller
Anja Schmidt
Ulrich Bothe
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MX2008000070A publication Critical patent/MX2008000070A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
MX2008000070A 2005-06-24 2006-06-22 Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona. MX2008000070A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren
PCT/EP2006/006532 WO2006136462A1 (en) 2005-06-24 2006-06-22 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
MX2008000070A true MX2008000070A (es) 2008-03-19

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008000070A MX2008000070A (es) 2005-06-24 2006-06-22 Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona.

Country Status (22)

Country Link
EP (1) EP1899315A1 (ru)
JP (1) JP2008543911A (ru)
KR (1) KR20080018275A (ru)
CN (1) CN101248056A (ru)
AR (1) AR057409A1 (ru)
AU (1) AU2006261049A1 (ru)
BR (1) BRPI0612305A2 (ru)
CA (1) CA2611900A1 (ru)
CR (1) CR9595A (ru)
DE (1) DE102005030294A1 (ru)
DO (1) DOP2006000150A (ru)
EA (1) EA200702604A1 (ru)
EC (1) ECSP078043A (ru)
GT (1) GT200600272A (ru)
IL (1) IL188022A0 (ru)
MX (1) MX2008000070A (ru)
NO (1) NO20080441L (ru)
PE (1) PE20070170A1 (ru)
TW (1) TW200738665A (ru)
UY (1) UY29626A1 (ru)
WO (1) WO2006136462A1 (ru)
ZA (1) ZA200800689B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
IN2014DN10548A (ru) 2012-05-31 2015-08-21 Repros Therapeutics Inc
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
CA2371273A1 (en) * 1999-05-04 2000-11-09 Andrew Fensome Tetracyclic progesterone receptor modulator compounds and methods
ATE346058T1 (de) * 2002-01-14 2006-12-15 Boehringer Ingelheim Pharma Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
AU2003209720A1 (en) * 2002-03-11 2003-09-22 Schering Ag 5-{2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
DE10346939A1 (de) * 2003-10-06 2005-05-19 Schering Ag Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Also Published As

Publication number Publication date
CR9595A (es) 2008-05-05
JP2008543911A (ja) 2008-12-04
NO20080441L (no) 2008-03-07
CN101248056A (zh) 2008-08-20
DE102005030294A1 (de) 2007-01-04
WO2006136462A1 (en) 2006-12-28
KR20080018275A (ko) 2008-02-27
GT200600272A (es) 2007-08-20
ZA200800689B (en) 2009-07-29
ECSP078043A (es) 2008-01-23
AU2006261049A1 (en) 2006-12-28
PE20070170A1 (es) 2007-03-02
EA200702604A1 (ru) 2008-06-30
DOP2006000150A (es) 2006-12-31
EP1899315A1 (en) 2008-03-19
TW200738665A (en) 2007-10-16
CA2611900A1 (en) 2006-12-28
AR057409A1 (es) 2007-12-05
UY29626A1 (es) 2007-01-31
IL188022A0 (en) 2008-03-20
BRPI0612305A2 (pt) 2010-11-03

Similar Documents

Publication Publication Date Title
TN2012000028A1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases
WO2011009530A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
WO2011009529A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
MX2008000070A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona.
TW200637827A (en) Processes for preparing substituted phenylpyrazole ureas
MX2009009581A (es) Indazoles usados para tratar trastornos mediados por el receptor de estrogenos beta.
GEP20146101B (en) Pyridine and pyrazine derivatives as protein kinase modulators
NO20063760L (no) Selektive ostrogenreseptormodulatorer for behandling av vasomotoriske symptomer
MX2007002393A (es) Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6).
MX2009007104A (es) Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina.
CU20120175A7 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
HK1132742A1 (en) Substituted oxindole derivative and its use as a vasopressin receptor modulator
DK2018170T3 (da) Lægemiddel mod brystcancer
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
WO2011009534A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
TW200613315A (en) Estradiol prodrugs
TW200740778A (en) Non-steroidal progesterone receptor modulators
UY29625A1 (es) Uso de moduladores no esteroides de receptores de progesterona
UA92500C2 (ru) Цианопирролсульфонамидные модуляторы прогестеронового рецептора и их применение
HRP20110780T1 (en) Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
WO2008113851A3 (en) Novel c11 modified retrosteroids as progesterone receptor modulator compounds
WO2008077647A3 (de) Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren
TN2010000007A1 (en) 8-beta- substituted estratrienes as selectively active estrogens
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona

Legal Events

Date Code Title Description
FA Abandonment or withdrawal